Mad Dash to Coronavirus Vaccine May Face Legal Hurdles
“Under the Bayh-Dole Act of 1980, the government can retain ownership rights in some patents for inventions generated by government-funded research…. The particular intellectual property issues raised by the new coronavirus vaccine vary wildly by who, and in what circumstances, the vaccine is developed.” Almost a third of the recently signed $8.3 billion bill to fund the United States response to the coronavirus outbreak is devoted directly to vaccine research and development. And while the realities of drug development and FDA approval mean it is unlikely any vaccine will be available before next year, the government has numerous tools at its...
Continue reading